Keywords
radiotherapy
retrospective cohort
toxicity
Burkina Faso
How to Cite
Abstract
Introduction :
Breast cancer is a heterogeneous disease managed through a multimodal strategy combining surgery, systemic therapies, and radiotherapy. This study aimed to describe the sociodemographic, clinical, pathological, therapeutic, and early outcome characteristics of patients receiving curative-intent radiotherapy at Bogodogo University Hospital.
Materials and methods :
This single-center retrospective cohort included 98 patients with histologically confirmed breast cancer who completed a first course of curative-intent external beam radiotherapy between April 2023 and December 2025. The administrative censoring date was April 30, 2026.
Results :
The mean age was 49.7 years and the median age was 48 years. Stage IIIA and IIIB disease accounted for 42.9 % of cases. The median interval from surgery to radiotherapy was 214.5 days (IQR, 130–352; range, 51–739 days). Acute toxicities were documented in 9.2 % of patients and treatment interruptions in 7.1 %. Six deaths had occurred by the censoring date.
Conclusion :
This cohort showed a substantial proportion of locally advanced breast cancers and prolonged intervals between surgery and radiotherapy.
References
1. Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, et al. Breast cancer. Nat Rev Dis Primers. 2019;5(1):66.
2. Loibl S, André F, Bachelot T, Barrios CH, Bergh J, Burstein HJ, et al. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2024;35(2):159-82.
3. Beltrán Ponce SE, Abunike SA, Bikomeye JC, Sieracki R, Niyonzima N, Mulamira P, et al. Access to radiation therapy and related clinical outcomes in patients with cervical and breast cancer across sub-Saharan Africa: a systematic review. JCO Glob Oncol. 2023;9:e2200218.
4. Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT, et al. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(8):1194-220.
5. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet. 2011;378(9804):1707-16.
6. Wang Y, Shen J, Gu P, Wang Z. Recent advances progress in radiotherapy for breast cancer after breast-conserving surgery: a review. Front Oncol. 2023;13:1195266.
7. Haussmann J, Budach W, Strnad V, Corradini S, Krug D, Schmidt L, et al. Comparing local and systemic control between partial- and whole-breast radiotherapy in low-risk breast cancer: a meta-analysis of randomized trials. Cancers (Basel). 2021;13(12):2967.
8. Coyle DJ, McClean B, Woods R, Duane F, Nicholson J, McArdle O. Resource implications of evolving breast cancer radiotherapy treatment protocols. Breast. 2024;78:103816.
9. Anyigba CA, Awandare GA, Paemka L. Breast cancer in sub-Saharan Africa: the current state and uncertain future. Exp Biol Med (Maywood). 2021;246(12):1377-87.
10. Tfayli A, Temraz S, Abou Mrad R, Shamseddine A. Breast cancer in low- and middle-income countries: an emerging and challenging epidemic. J Oncol. 2010;2010:490631.
11. Martei YM, Dauda B, Vanderpuye V. Breast cancer screening in sub-Saharan Africa: a systematic review and ethical appraisal. BMC Cancer. 2022;22(1):203.
12. Kim J, Macharia PM, McCormack V, Foerster M, Galukande M, Joffe M, et al. Geospatial disparities in survival of patients with breast cancer in sub-Saharan Africa from the African Breast Cancer-Disparities in Outcomes cohort (ABC-DO): a prospective cohort study. Lancet Glob Health. 2024;12(7):e1111-9.
13. Jedy-Agba E, McCormack V, Adebamowo C, dos-Santos-Silva I. Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2016;4(12):e923-35.
14. Wu TC, McCloskey SA. Established and new horizons in radiotherapy for breast cancer. Ther Adv Med Oncol. 2023;15:17588359231161415.
15. Marta GN, AlBeesh R, Pereira AAL, Oliveira LJ, Mano MS, Hijal T. The impact on clinical outcomes of postoperative radiation therapy delay after neoadjuvant chemotherapy in patients with breast cancer: a multicentric international study. Breast. 2020;54:46-51.
16. Lesage M, Pilloy J, Fleurier C, Cirier J, Jourdan ML, Arbion F, et al. Impact pronostique du délai d'induction de la radiothérapie adjuvante dans le cancer du sein. Gynecol Obstet Fertil Senol. 2019;47(6):516-21.
Metrics
Downloads
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 S Panandtigri, A Dao, NPX Sia, BG Compaore, NAA Minoungou, I Coulibaly, N Zongo